VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
IMP Application KM-001
Phase 1
Small molecule
K
Kamari Pharma Ltd
1
Indications
1
Total Trials
0
Active Trials
0
Competitors
Clinical
Trials by Indication
[1]
Pruritus
1 trial
KM-001 Cream for Treatment of Pruritus in Adult Patients With Lichen Simplex Chronicus (LSC)
Completed
·
K
Kamari Pharma Ltd
·
Phase 1
·
NCT05454462
·
55 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for IMP Application KM-001. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
IMP Application KM-001 compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for IMP Application KM-001. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Kamari Pharma Ltd company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Phase 1
[1]
Company
K
Kamari Pharma Ltd
Related News